½ÃÀ庸°í¼­
»óǰÄÚµå
1548157

¼¼°è ´Ü¹éÁú ½ÃÄö½Ì ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2024-2032³â)

Global Protein Sequencing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 170 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

´Ü¹éÁú ½ÃÄö½Ì ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 27¾ï 8,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â 41¾ï 3,000¸¸ ´Þ·¯ ±Ùó ½ÃÀå ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ 2024-2032³âÀÇ CAGRÀº 4.5%·Î ÃßÁ¤µË´Ï´Ù.

´Ü¹éÁú ½ÃÄö½ÌÀº ´Ü¹éÁúÀÇ ¾Æ¹Ì³ë»ê ¼­¿­À» °áÁ¤ÇÏ´Â µ¥ »ç¿ëµÇ´Â ±â¼úÀÌ¸ç ´Ü¹éÁúÀÇ ±¸Á¶, ±â´É ¹× »óÈ£ ÀÛ¿ëÀ» ÀÌÇØÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ °úÁ¤¿¡¼­´Â ´Ü¹éÁúÀ» ´õ ÀÛÀº ÆéƼµå ´ÜÆíÀ¸·Î ºÐÇØÇϰí Áú·® ºÐ¼®¹ý ¶Ç´Â ¿¡µå¸¸ ºÐÇØ¹ýÀ» »ç¿ëÇÏ¿© ºÐ¼®ÇÕ´Ï´Ù. ¾òÀº ¼­¿­ µ¥ÀÌÅÍ´Â ´Ü¹éÁúÀÇ 1Â÷ ±¸Á¶¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÏ°í ¿¬±¸ÀÚ°¡ »ý¹°ÇÐÀû ¿ªÇÒ°ú ¸ÞÄ¿´ÏÁòÀ» ÇØ¸íÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÄö½ÌÀº ´Ü¹éÁúüÇÐ, â¾à, »ý¸í°øÇÐ µî ´Ù¾çÇÑ ºÐ¾ßÀÇ ±âÃʰ¡ µÇ¾î ´Ü¹éÁú ¹ÙÀÌ¿À¸¶Ä¿ÀÇ µ¿Á¤, ½Å±Ô Ä¡·áÁ¦ÀÇ °³¹ß, Áúȯ ¸ÞÄ¿´ÏÁòÀÇ ÇØ¸í µî¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½ÃÄö½Ì ±â¼ú ¹× ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ÅøÀÇ Áøº¸´Â ÀÌ ½ÃÄö½ÌÀÇ Á¤È®¼º, ¼Óµµ, ºñ¿ë È¿À²¼ºÀ» Å©°Ô Çâ»ó½ÃÄÑ Çö´ë ºÐÀÚ »ý¹°ÇÐ ¹× »ý¹°ÀÇÇÐ ¿¬±¸¿¡ ÇʼöÀûÀÎ ¿ä¼Ò°¡ µÇ¾ú½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

´Ü¹éÁú ½ÃÄö½Ì ½ÃÀåÀº ¸ÂÃãÇü ÀÇ·á ¹× Ç¥Àû ¿ä¹ý¿¡ ´ëÇÑ °ü½É Áõ°¡¿¡ ÈûÀÔ¾î ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¿¬±¸ÀÚ¿Í ÀÓ»óÀǰ¡ °³ÀÎÀÇ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ¸ÂÃá Ä¡·á¹ýÀÇ °³¹ßÀ» ¸ð»öÇÏ´Â µ¿¾È ´Ü¹éÁú ½ÃÄö½ÌÀº ¹ÙÀÌ¿À¸¶Ä¿ÀÇ µ¿Á¤°ú ºÐÀÚ ¼öÁØ¿¡¼­ÀÇ Áúº´ ¸ÞÄ¿´ÏÁòÀÇ ÀÌÇØ¿¡ ÇʼöÀûÀÌ µÇ°í ÀÖ½À´Ï´Ù. Á¤¹ÐÇÑ ´Ü¹éÁúÀ» ½ÃÄö½ÌÇÔÀ¸·Î½á Ç¥Àû Ä¡·á¿Í ¸ÂÃãÇü Ä¡·á °èȹÀÇ °³¹ßÀÌ °¡´ÉÇØÁ®, ÇコÄɾî¿Í »ý¸í°øÇÐ ºÐ¾ß ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ½ÃÄö½Ì ±â¼úÀÇ ±â¼úÀû Áøº¸´Â ½ÃÀå¿¡ Å« ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Â÷¼¼´ë ½ÃÄö½Ì(NGS) ¹× °í󸮷® Áú·® ºÐ±¤°è¿Í °°Àº ±â¼ú Çõ½ÅÀ¸·Î ÀÌ ½ÃÄö½ÌÀÇ ¼Óµµ, Á¤È®¼º ¹× ºñ¿ë È¿À²¼ºÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸´Â Á¾ÇÕÀûÀÎ ÇÁ·ÎÅ×¿È ºÐ¼®À» °¡´ÉÇÏ°Ô Çϰí, ´ë±Ô¸ð ¿¬±¸¸¦ ¿ëÀÌÇÏ°Ô Çϰí, ¿¬±¸ ¹× ÀÓ»ó ȯ°æ¿¡¼­ ÀÌ ½ÃÄö½ÌÀÇ ÀÀ¿ë °¡´É¼ºÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù.

Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö »ê¾÷ÀÇ ¼ºÀåµµ ½ÃÀå ±âȸ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ »ê¾÷ÀÌ Ã¢¾à°ú ¾à¹° °³¹ß¿¡ ÅõÀÚÇÏ´Â µ¿¾È, ´Ü¹éÁú ½ÃÄö½ÌÀº ÀáÀçÀûÀΠâ¾à Ç¥ÀûÀ» È®ÀÎÇϰí ÀÛ¿ë ¸ÞÄ¿´ÏÁòÀ» ÀÌÇØÇϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¾÷°è¿¡¼­´Â R&D¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ °í±Þ ½ÃÄö½Ì ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º¿Í µ¥ÀÌÅÍ ºÐ¼® ÅøÀÇ µîÀåÀº ÀÌ·¯ÇÑ ½ÃÄö½ÌÀÇ À¯¿ë¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. °í±Þ ¼ÒÇÁÆ®¿þ¾î¿Í ¾Ë°í¸®ÁòÀ» ÅëÇØ ¿¬±¸ÀÚ´Â º¹ÀâÇÑ ½ÃÄö½Ì µ¥ÀÌÅ͸¦ ÇØ¼®Çϰí, ´Ü¹éÁúÀÇ º¯ÇüÀ» È®ÀÎÇϰí, °á°ú¸¦ »ý¹°ÇÐÀû ±â´É°ú ¿¬°ü½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½ºÀÇ ÅëÇÕÀº °¡Ä¡ÀÖ´Â ÅëÂû·ÂÀ» Á¦°øÇÏ°í µ¥ÀÌÅÍ Áß½ÉÀÇ ¹ß°ßÀ» ÃËÁøÇÔÀ¸·Î½á ½ÃÀå ¼ºÀåÀ» Áö¿øÇÕ´Ï´Ù. ±×·¯³ª °í±Þ ½ÃÄö½Ì ±â¼ú°ú µ¥ÀÌÅÍ ºÐ¼®ÀÇ º¹À⼺À¸·Î ÀÎÇÑ °íºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ »ó¼¼ÇÑ ½ÃÀå Á¶»ç´Â ¿©·¯ Ãâó¿¡¼­ ÀÔ¼öÇÑ µ¥ÀÌÅ͸¦ Áß½ÉÀ¸·Î Porter's Five Forces ºÐ¼®, ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼® µî ¼ö¸¹Àº ÅøÀ» ÀÌ¿ëÇÏ¿© ºÐ¼®Çß½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ½ÃÀåÀÇ ÀáÀçÀû °¡Ä¡¸¦ ÅëÂûÇÏ´Â µ¥ »ç¿ëµÇ¸ç ºñÁî´Ï½º Àü·«°¡¿¡°Ô ÃֽмºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ µµ±¸´Â ´Ü¹éÁú ½ÃÄö½Ì ¼¼°è ½ÃÀå¿¡¼­ °¢ ÀÀ¿ë/Á¦Ç° ºÎ¹®ÀÇ »ó¼¼ÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

±¤¹üÀ§ÇÑ ´Ü¹éÁú ½ÃÄö½Ì ½ÃÀåÀº Á¦Ç° ¹× ¼­ºñ½º, ±â¼ú, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ·Î ¼¼ºÐÈ­µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ º¸°í¼­´Â Áö¸®Àû ¼¼ºÐÈ­¿Í °ü·ÃÇÏ¿© ÀÌ·¯ÇÑ ÇÏÀ§ ÁýÇÕÀ» Á¶»çÇß½À´Ï´Ù. Àü·«°¡´Â »ó¼¼ÇÑ ÅëÂû·ÂÀ» ¾ò¾î ƯÁ¤ ½ÃÀåÀ» Ÿ°ÙÆÃÇÏ´Â ÀûÀýÇÑ Àü·«À» °í¾ÈÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¼¼ºÎ »çÇ×Àº ´õ ³ªÀº ±âȸ¸¦ ÆÄ¾ÇÇÏ´Â Áß¾Ó ÁýÁᫎ Á¢±Ù ¹æ½ÄÀ¸·Î À̾îÁý´Ï´Ù.

Á¦Ç° ¹× ¼­ºñ½ºº°

  • ´Ü¹éÁú ½ÃÄö½Ì Á¦Ç°(½Ã¾à ¹× ¼Ò¸ðǰ, ÀåÄ¡(Áú·® ºÐ¼® ÀåÄ¡, ¿¡µå¸¸ ºÐÇØ ½ÃÄö¼­), ¼ÒÇÁÆ®¿þ¾î)
  • ´Ü¹éÁú ½ÃÄö½Ì ¼­ºñ½º

¿ëµµº°

  • ¹ÙÀÌ¿À Ä¡·áÁ¦
  • À¯ÀüÀÚ °øÇÐ
  • ±âŸ

ÃÖÁ¾ »ç¿ëÀÚº°

  • Çмú±â°ü ¹× ¿¬±¸¼¾ÅÍ
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ±âŸ
  • Áö¿ªº° ºÐ¼®
  • ¶ÇÇÑ ÀÌ º¸°í¼­´Â ÁÖ·Î ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ ´Ü¹éÁú ½ÃÄö¼­ ¼ö¿ä¿Í ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃá Áö¸®Àû ¼¼ºÐÈ­·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. º¸°í¼­´Â ¶ÇÇÑ ¸ðµç Áö¿ª¿¡¼­ °³º° ÀÀ¿ë ºÐ¾ß ¼ö¿ä¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖ´Â °æ¿ì ´ç»ç¿¡ ¹®ÀÇÇϼ¼¿ä. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå ´Ü¹éÁú ½ÃÄö½Ì-»ê¾÷ ºÐ¼®

  • ¼Ò°³: ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ±¸¸ÅÀÚ ¸ñ·Ï
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ´Ü¹éÁú ½ÃÄö½Ì ¼¼°è ½ÃÀå ºÐ¼® : Á¦Ç° ¹× ¼­ºñ½ºº°

  • °³¿ä Á¦Ç° ¹× ¼­ºñ½ºº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • Á¦Ç° ¹× ¼­ºñ½ºº° ºÐ¼®
  • ´Ü¹éÁú ½ÃÄö½Ì Á¦Ç°(½Ã¾à ¹× ¼Ò¸ðǰ, ÀåÄ¡(Áú·® ºÐ¼® ÀåÄ¡, ¿¡µå¸¸ ºÐÇØ ½ÃÄö¼­), ¼ÒÇÁÆ®¿þ¾î)
  • ´Ü¹éÁú ½ÃÄö½Ì ¼­ºñ½º

Á¦6Àå ¼¼°èÀÇ ´Ü¹éÁú ½ÃÄö½Ì ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ¿ëµµº°
  • ¹ÙÀÌ¿À Ä¡·áÁ¦
  • À¯ÀüÀÚ °øÇÐ
  • ±âŸ

Á¦7Àå ´Ü¹éÁú ½ÃÄö½Ì ¼¼°è ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • °³¿ä ÃÖÁ¾ »ç¿ëÀÚº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ÃÖÁ¾ »ç¿ëÀÚº° ºÐ¼®
  • Çмú±â°ü ¹× ¿¬±¸¼¾ÅÍ
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ±âŸ

Á¦8Àå ´Ü¹éÁú ½ÃÄö½Ì ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼Ò°³
  • ºÏ¹Ì ¸ÅÃ⠺м®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ìº°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • À¯·´ ºÎ¹®º°
    • À¯·´ ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ±¹°¡º° À϶÷
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ´Ü¹éÁú ½ÃÄö½Ì ±â¾÷°æÀï ±¸µµ

  • ´Ü¹éÁú ½ÃÄö½Ì ½ÃÀåÀÇ °æÀï
  • ÆÄÆ®³Ê½Ê/Á¦ÈÞ/ÇÕÀÇ
  • ÇÕº´ ¹× Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Thermo Fisher Scientific Inc.
  • Shimadzu Corporation
  • Agilent Technologies Inc.
  • Rapid Novor Inc.
  • Charles River Laboratories
  • Proteome Factory AG
  • Selvita
  • Bioinformatics Solutions Inc.
  • Creative Proteomics
  • Alphalyse
  • Bruker.
JHS 24.10.02

The global demand for Protein Sequencing Market is presumed to reach the market size of nearly USD 4.13 Billion by 2032 from USD 2.78 Billion in 2023 with a CAGR of 4.5% under the study period 2024 - 2032.

Protein sequencing is a technique employed to determine the amino acid sequence of proteins, which is crucial for understanding their structure, function, and interactions. This process involves breaking down proteins into smaller peptide fragments, which are then analyzed using mass spectrometry or Edman degradation methods. The resulting sequence data provides insights into the protein's primary structure, helping researchers to elucidate its biological roles and mechanisms. These sequencing is fundamental in various fields, including proteomics, drug discovery, and biotechnology, where it aids in identifying protein biomarkers, developing new therapeutics, and understanding disease mechanisms. Advances in sequencing technologies & bioinformatics tools have significantly enhanced the accuracy, speed, and cost-effectiveness of this sequencing, making it a vital component of modern molecular biology and biomedical research.

Market Dynamics

The protein sequencing market is experiencing growth fuelled by the propelling focus on personalized medicine & targeted therapies. As researchers and clinicians seek to develop treatments tailored to individual genetic profiles, protein sequencing becomes essential for identifying biomarkers and understanding disease mechanisms at a molecular level. Sequencing high-precision proteins enables the development of targeted therapies and personalized treatment plans, driving demand in the healthcare and biotechnology sectors. Technological advancements in sequencing technologies present significant opportunities for the market. Innovations such as next-generation sequencing (NGS) and high-throughput mass spectrometry have greatly improved the speed, accuracy, and cost-effectiveness of this sequencing. These advancements allow for comprehensive proteomic analysis and facilitate large-scale studies, expanding the potential applications of this sequencing in research and clinical settings.

The growth of the pharmaceutical & biotechnology industries also contributes to market opportunities. As these industries invest in drug discovery and development, protein sequencing plays a crucial role in identifying potential drug targets & understanding the mechanisms of action. The increasing investment in research and development within these sectors drives demand for advanced sequencing technologies. The rise of bioinformatics and data analysis tools enhances the utility of these sequencing. Advanced software and algorithms enable researchers to interpret complex sequencing data, identify protein modifications, and correlate findings with biological functions. This integration of bioinformatics supports market growth by providing valuable insights and facilitating data-driven discoveries. However, high costs associated with advanced sequencing technologies and data analysis complexity can hinder market growth.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of protein sequencing.

Market Segmentation

The broad protein sequencing market has been sub-grouped into product & service, technology, application and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Product & Service

  • Protein Sequencing Products (Reagents & Consumables, Instruments (Mass Spectrometry Instruments, Edman Degradation Sequencers), Software)
  • Protein Sequencing Services

By Application

  • Bio-therapeutics
  • Genetic Engineering
  • Others

By End-user

  • Academic Institutes & Research Centers
  • Pharmaceutical & Biotechnology Companies
  • Others
  • Regional Analysis
  • Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for protein sequencing in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
  • The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Protein Sequencing market include Thermo Fisher Scientific Inc., Shimadzu Corporation, Agilent Technologies Inc., Rapid Novor Inc., Charles River Laboratories, Proteome Factory AG, Selvita, Bioinformatics Solutions Inc., Creative Proteomics, Alphalyse, Bruker. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PROTEIN SEQUENCING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PROTEIN SEQUENCING MARKET ANALYSIS BY PRODUCT & SERVICE

  • 5.1. Overview By Product & Service
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product & Service
  • 5.4. Protein Sequencing Products (Reagents & Consumables, Instruments (Mass Spectrometry Instruments, Edman Degradation Sequencers), Software) Historic and Forecast Sales By Regions
  • 5.5. Protein Sequencing Services Historic and Forecast Sales By Regions

6. GLOBAL PROTEIN SEQUENCING MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Application
  • 6.4. Bio-therapeutics Historic and Forecast Sales By Regions
  • 6.5. Genetic Engineering Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL PROTEIN SEQUENCING MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By End-user
  • 7.4. Academic Institutes & Research Centers Historic and Forecast Sales By Regions
  • 7.5. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL PROTEIN SEQUENCING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PROTEIN SEQUENCING COMPANIES

  • 9.1. Protein Sequencing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF PROTEIN SEQUENCING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Thermo Fisher Scientific Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Shimadzu Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Agilent Technologies Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Rapid Novor Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Charles River Laboratories
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Proteome Factory AG
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Selvita
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Bioinformatics Solutions Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Creative Proteomics
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Alphalyse
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Bruker.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦